Uploaded November 2024 | Updated September 2026, 1 week ago
To explore the potential of multi modal transformers and diffusion models in learning longitudinal multiomics and development of the body world models, Insilico Medicine started working on the PreciousGPT series in 2022 (insilico.com/precious).
Precious3GPT is our latest development in generative biomedicine. It is the first multi omics multispecies multi tissue multimodal transformer model for aging research and drug discovery which trained on biomedical text data, and multiple data types coming from different species.
Follow the video to see how PreciousGPT3 uses biological data to do deep analysis.
To explore the potential of multi modal transformers and diffusion models in learning longitudinal multiomics and development of the body world models, Insilico Medicine started working on the PreciousGPT series in 2022 (insilico.com/precious).
Precious3GPT is our latest development in generative biomedicine. It is the first multi omics multispecies multi tissue multimodal transformer model for aging research and drug discovery which trained on biomedical text data, and multiple data types coming from different species.
Follow the video to see how PreciousGPT3 uses biological data to do deep analysis.
![[Nature Communications] Oral ENPP1 Inhibitor as Next Generation STING Modulator for Solid Tumors](https://i.ytimg.com/vi/R9wa1NeqVZg/mqdefault.jpg "[Nature Communications] Oral ENPP1 Inhibitor as Next Generation STING Modulator for Solid Tumors
Cold tumors are cancers with little to no immune cell infiltration. They lack the ability to activate the immune system, leaving patients with few options. Recently, Insilico Medicine announced breakthrough findings in immune oncology therapy targeting ENPP1, published in Nature Communications, a leading peer reviewed journal.")
